Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhaohan Pharmaceutical Technology Research Institute is a specialized contract research organization (CRO) located in Beijing, China, and is a wholly-owned subsidiary of Joinn Laboratories. The institute primarily focuses on providing clinical trial management and pharmaceutical research services to support the global drug development industry. Its core offerings include preclinical safety assessments, clinical pharmacology, and regulatory consulting, ensuring compliance with international standards such as GLP and GCP. As a key clinical service arm of the Joinn group, it facilitates the transition of drug candidates from laboratory research to human clinical trials. The institute serves a diverse clientele ranging from emerging biotech startups to established multinational pharmaceutical corporations. Through its integrated service platform, Beijing Zhaohan helps streamline the path to market for innovative therapies across multiple therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhaohan Pharmaceutical Technology Research Institute.